G. Ivaldi

发表

M. Neri, R. Puntoni, A. Ardizzoni, 2005, Tumor Biology.

The Liverpool Care Pathway for cancer patients dying in hospital medical wards: A before–after cluster phase II trial of outcomes reported by family members

I. Higginson, M. Costantini, F. Pellegrini, 2014, Palliative medicine.

Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma

B. Christensen, C. Marsit, D. Sugarbaker, 2010, International journal of cancer.

The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.

B. Parodi, S. Bonassi, C. Lando, 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA

S. Parodi, D. Ugolini, R. Filiberti, 2013, Medical Oncology.

Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure.

S. Bonassi, C. Bolognesi, M. Neri, 2005, Mutation research.

Differential diagnosis of pleural mesothelioma using Logic Learning Machine

Marco Muselli, Enrico Ferrari, Stefano Parodi, 2015, BMC Bioinformatics.

Psychological and symptom distress in terminal cancer patients with met and unmet needs.

M. Costantini, W. Tirelli, P. Viterbori, 1999, Journal of pain and symptom management.

A bibliometric analysis of scientific production in mesothelioma research.

S. Bonassi, M. Ceppi, M. Neri, 2010, Lung cancer.

Correction

B. Parodi, C. Lando, M. Neri, 2014, Plant Cell.